NORWOOD, MA -- (MARKET WIRE) -- April 04, 2007 -- Apogee Technology, Inc. (AMEX: ATA), an emerging developer of advanced drug delivery systems, reported that it signed an exclusive license agreement with the Georgia Tech Research Corporation. Under this agreement, Apogee obtained exclusive rights to a U.S. patent application and know-how related to the design and manufacturing of microneedle-based drug delivery systems. The Company believes the technology, when fully developed, will support the efficient manufacturing of its PyraDerm™ intradermal drug delivery system as well as to increase its utility and potential market applications.
